WHO Report Highlights Lifesaving Impact of Vaccinations in Africa
The World Health Organization has released a landmark analysis revealing that vaccination programs across Africa have saved more than 50 million lives over the past five decades. This monumental achievement has contributed significantly to public health, with the agency estimating that each infant life saved has gained approximately 60 years of life expectancy. The comprehensive study, the first of its kind for the region, underscores the critical role of immunization in combating disease and improving longevity.
Progress and Milestones in Immunization Efforts
Since the year 2000, routine vaccination initiatives have reached over 500 million children in Africa, preventing an estimated 4 million deaths annually. In 2024 alone, vaccines saved nearly 2 million lives, marking a continued positive trend. Key public health victories include the eradication of wild poliovirus in 2020, described as a historic milestone for the continent, and the elimination of maternal and neonatal tetanus in most African nations.
Furthermore, vaccines against malaria, a disease that claims more than 400,000 lives each year—primarily children under five in Africa—are now being introduced in 25 countries. Mohamed Janabi, the WHO regional director for Africa, hailed this development as a major scientific and public health breakthrough during a recent online press briefing.
Challenges and Slowing Progress in Some Regions
Despite these successes, the WHO warns that progress is uneven and slowing in certain areas. The COVID-19 pandemic exacerbated existing disparities, increasing the number of children who have never received a single vaccine. Ten countries account for 80% of these unvaccinated children in the region, highlighting what Janabi described as a profound equity issue.
Sania Nishtar, chief executive of Gavi, the Vaccine Alliance, which partners with the WHO, emphasized the need for consistent outreach. She stated that immunization outcomes reflect very different realities, and more work is required to ensure children in fragile and remote contexts are reached effectively.
Threats from US Aid Cuts and Middle East Conflict
The report comes amid growing concerns over external threats to immunization programs. Aid cuts following the return of former US President Donald Trump to the White House in 2025 have had devastating effects. Janabi noted that the US withdrawal from the WHO in January resulted in the loss of about 40% of the agency's overseas development funding, urging African governments to increase domestic health financing to mitigate the impact.
Additionally, the war between the US and Iran has disrupted supply chains and increased gas prices, posing further challenges. Adelheid Onyango, the WHO Africa director for health systems and services, expressed concern, noting that many health facilities in Africa depend on generators. The agency has yet to quantify the full impact of the conflict on immunization efforts.
Funding Emerges as Critical Concern for Future Efforts
Health experts warn that funding is becoming the biggest threat to Africa's immunization programs as Western donors, including the US, tighten aid to poorer countries. Shabir Madhi, a professor of vaccinology at South Africa's University of the Witwatersrand, highlighted that aid-funded programs have already scaled back or shut down in many nations, reducing access to essential health services such as clinics, health workers, and cold-chain infrastructure.
Madhi stressed the need for greater self-reliance, pointing out that Gavi, the Vaccine Alliance, is experiencing a financial crunch. He called for discussions on what percentage of immunization programs should be funded by African countries themselves to ensure broader vaccine coverage and not just a few children benefiting.
The WHO's analysis serves as both a celebration of past achievements and a stark reminder of the vulnerabilities facing public health initiatives in Africa. Without sustained funding and stable geopolitical conditions, the hard-won gains in vaccination coverage could be at risk, potentially reversing decades of progress in saving lives and improving health outcomes across the continent.
